IMINE COMPOUND
An imine compound represented by the formula: wherein A represents a heterocyclic group; R 1 , R 2 , an R 3 each represent a hydrogen atom, a halogen atom, a C 1-10 alkyl group optionally substituted with an aryl group(s) substituted with a halogen atom (s), a C 3-10 cycloalkyl group, a C 1-6 haloal...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SEKINE, SHINGO MORITA, AKI YOSHIMURA, HIROMITSU OHTA, HIROSHI TOKUGAWA, KIMIKO YOSHINAGA, MITSUKANE TODA, YOSHIHISA TOMISHIMA, YASUMITSU TATSUZUKI, MAKOTO KAKU, AYAKA SAITO, SHIUJI MURAKAMI, TOMOMI ISHIZAKA, TOMOKO YOSHIMIZU, TAKAO YOKOBORI, YUJI |
| description | An imine compound represented by the formula:
wherein A represents a heterocyclic group; R 1 , R 2 , an R 3 each represent a hydrogen atom, a halogen atom, a C 1-10 alkyl group optionally substituted with an aryl group(s) substituted with a halogen atom (s), a C 3-10 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-10 alkoxy group, etc.; R 4 represents an optionally substituted C 1-10 alkyl, C 2-6 alkenyl, or aryl group; R 5 represents a hydrogen atom, a C 1-10 alkoxy group, a C 1-6 haloalkyl group, an optionally substituted C 1-10 alkyl or C 2-6 alkenyl group, an optionally substituted aryl or heterocyclic group, etc.; W represents -CO-, -CO-CO-, -CO-NH-, -CS-NH-, or -SO 2 -,
or a cannabinoid-receptor agonist comprising said imine compound as an active ingredient. The imine compound of the present invention has a cannabinoid-receptor agonist effect, and is useful as a therapeutic or prophylactic drug for pains and autoimmune diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1820504A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1820504A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1820504A13</originalsourceid><addsrcrecordid>eNrjZODz9PX0c1Vw9vcN8A_1c-FhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAYYWRgamBiaOhsZEKAEAj_gcfA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMINE COMPOUND</title><source>esp@cenet</source><creator>SEKINE, SHINGO ; MORITA, AKI ; YOSHIMURA, HIROMITSU ; OHTA, HIROSHI ; TOKUGAWA, KIMIKO ; YOSHINAGA, MITSUKANE ; TODA, YOSHIHISA ; TOMISHIMA, YASUMITSU ; TATSUZUKI, MAKOTO ; KAKU, AYAKA ; SAITO, SHIUJI ; MURAKAMI, TOMOMI ; ISHIZAKA, TOMOKO ; YOSHIMIZU, TAKAO ; YOKOBORI, YUJI</creator><creatorcontrib>SEKINE, SHINGO ; MORITA, AKI ; YOSHIMURA, HIROMITSU ; OHTA, HIROSHI ; TOKUGAWA, KIMIKO ; YOSHINAGA, MITSUKANE ; TODA, YOSHIHISA ; TOMISHIMA, YASUMITSU ; TATSUZUKI, MAKOTO ; KAKU, AYAKA ; SAITO, SHIUJI ; MURAKAMI, TOMOMI ; ISHIZAKA, TOMOKO ; YOSHIMIZU, TAKAO ; YOKOBORI, YUJI</creatorcontrib><description>An imine compound represented by the formula:
wherein A represents a heterocyclic group; R 1 , R 2 , an R 3 each represent a hydrogen atom, a halogen atom, a C 1-10 alkyl group optionally substituted with an aryl group(s) substituted with a halogen atom (s), a C 3-10 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-10 alkoxy group, etc.; R 4 represents an optionally substituted C 1-10 alkyl, C 2-6 alkenyl, or aryl group; R 5 represents a hydrogen atom, a C 1-10 alkoxy group, a C 1-6 haloalkyl group, an optionally substituted C 1-10 alkyl or C 2-6 alkenyl group, an optionally substituted aryl or heterocyclic group, etc.; W represents -CO-, -CO-CO-, -CO-NH-, -CS-NH-, or -SO 2 -,
or a cannabinoid-receptor agonist comprising said imine compound as an active ingredient. The imine compound of the present invention has a cannabinoid-receptor agonist effect, and is useful as a therapeutic or prophylactic drug for pains and autoimmune diseases.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070822&DB=EPODOC&CC=EP&NR=1820504A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070822&DB=EPODOC&CC=EP&NR=1820504A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SEKINE, SHINGO</creatorcontrib><creatorcontrib>MORITA, AKI</creatorcontrib><creatorcontrib>YOSHIMURA, HIROMITSU</creatorcontrib><creatorcontrib>OHTA, HIROSHI</creatorcontrib><creatorcontrib>TOKUGAWA, KIMIKO</creatorcontrib><creatorcontrib>YOSHINAGA, MITSUKANE</creatorcontrib><creatorcontrib>TODA, YOSHIHISA</creatorcontrib><creatorcontrib>TOMISHIMA, YASUMITSU</creatorcontrib><creatorcontrib>TATSUZUKI, MAKOTO</creatorcontrib><creatorcontrib>KAKU, AYAKA</creatorcontrib><creatorcontrib>SAITO, SHIUJI</creatorcontrib><creatorcontrib>MURAKAMI, TOMOMI</creatorcontrib><creatorcontrib>ISHIZAKA, TOMOKO</creatorcontrib><creatorcontrib>YOSHIMIZU, TAKAO</creatorcontrib><creatorcontrib>YOKOBORI, YUJI</creatorcontrib><title>IMINE COMPOUND</title><description>An imine compound represented by the formula:
wherein A represents a heterocyclic group; R 1 , R 2 , an R 3 each represent a hydrogen atom, a halogen atom, a C 1-10 alkyl group optionally substituted with an aryl group(s) substituted with a halogen atom (s), a C 3-10 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-10 alkoxy group, etc.; R 4 represents an optionally substituted C 1-10 alkyl, C 2-6 alkenyl, or aryl group; R 5 represents a hydrogen atom, a C 1-10 alkoxy group, a C 1-6 haloalkyl group, an optionally substituted C 1-10 alkyl or C 2-6 alkenyl group, an optionally substituted aryl or heterocyclic group, etc.; W represents -CO-, -CO-CO-, -CO-NH-, -CS-NH-, or -SO 2 -,
or a cannabinoid-receptor agonist comprising said imine compound as an active ingredient. The imine compound of the present invention has a cannabinoid-receptor agonist effect, and is useful as a therapeutic or prophylactic drug for pains and autoimmune diseases.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZODz9PX0c1Vw9vcN8A_1c-FhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAYYWRgamBiaOhsZEKAEAj_gcfA</recordid><startdate>20070822</startdate><enddate>20070822</enddate><creator>SEKINE, SHINGO</creator><creator>MORITA, AKI</creator><creator>YOSHIMURA, HIROMITSU</creator><creator>OHTA, HIROSHI</creator><creator>TOKUGAWA, KIMIKO</creator><creator>YOSHINAGA, MITSUKANE</creator><creator>TODA, YOSHIHISA</creator><creator>TOMISHIMA, YASUMITSU</creator><creator>TATSUZUKI, MAKOTO</creator><creator>KAKU, AYAKA</creator><creator>SAITO, SHIUJI</creator><creator>MURAKAMI, TOMOMI</creator><creator>ISHIZAKA, TOMOKO</creator><creator>YOSHIMIZU, TAKAO</creator><creator>YOKOBORI, YUJI</creator><scope>EVB</scope></search><sort><creationdate>20070822</creationdate><title>IMINE COMPOUND</title><author>SEKINE, SHINGO ; MORITA, AKI ; YOSHIMURA, HIROMITSU ; OHTA, HIROSHI ; TOKUGAWA, KIMIKO ; YOSHINAGA, MITSUKANE ; TODA, YOSHIHISA ; TOMISHIMA, YASUMITSU ; TATSUZUKI, MAKOTO ; KAKU, AYAKA ; SAITO, SHIUJI ; MURAKAMI, TOMOMI ; ISHIZAKA, TOMOKO ; YOSHIMIZU, TAKAO ; YOKOBORI, YUJI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1820504A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2007</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SEKINE, SHINGO</creatorcontrib><creatorcontrib>MORITA, AKI</creatorcontrib><creatorcontrib>YOSHIMURA, HIROMITSU</creatorcontrib><creatorcontrib>OHTA, HIROSHI</creatorcontrib><creatorcontrib>TOKUGAWA, KIMIKO</creatorcontrib><creatorcontrib>YOSHINAGA, MITSUKANE</creatorcontrib><creatorcontrib>TODA, YOSHIHISA</creatorcontrib><creatorcontrib>TOMISHIMA, YASUMITSU</creatorcontrib><creatorcontrib>TATSUZUKI, MAKOTO</creatorcontrib><creatorcontrib>KAKU, AYAKA</creatorcontrib><creatorcontrib>SAITO, SHIUJI</creatorcontrib><creatorcontrib>MURAKAMI, TOMOMI</creatorcontrib><creatorcontrib>ISHIZAKA, TOMOKO</creatorcontrib><creatorcontrib>YOSHIMIZU, TAKAO</creatorcontrib><creatorcontrib>YOKOBORI, YUJI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SEKINE, SHINGO</au><au>MORITA, AKI</au><au>YOSHIMURA, HIROMITSU</au><au>OHTA, HIROSHI</au><au>TOKUGAWA, KIMIKO</au><au>YOSHINAGA, MITSUKANE</au><au>TODA, YOSHIHISA</au><au>TOMISHIMA, YASUMITSU</au><au>TATSUZUKI, MAKOTO</au><au>KAKU, AYAKA</au><au>SAITO, SHIUJI</au><au>MURAKAMI, TOMOMI</au><au>ISHIZAKA, TOMOKO</au><au>YOSHIMIZU, TAKAO</au><au>YOKOBORI, YUJI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMINE COMPOUND</title><date>2007-08-22</date><risdate>2007</risdate><abstract>An imine compound represented by the formula:
wherein A represents a heterocyclic group; R 1 , R 2 , an R 3 each represent a hydrogen atom, a halogen atom, a C 1-10 alkyl group optionally substituted with an aryl group(s) substituted with a halogen atom (s), a C 3-10 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-10 alkoxy group, etc.; R 4 represents an optionally substituted C 1-10 alkyl, C 2-6 alkenyl, or aryl group; R 5 represents a hydrogen atom, a C 1-10 alkoxy group, a C 1-6 haloalkyl group, an optionally substituted C 1-10 alkyl or C 2-6 alkenyl group, an optionally substituted aryl or heterocyclic group, etc.; W represents -CO-, -CO-CO-, -CO-NH-, -CS-NH-, or -SO 2 -,
or a cannabinoid-receptor agonist comprising said imine compound as an active ingredient. The imine compound of the present invention has a cannabinoid-receptor agonist effect, and is useful as a therapeutic or prophylactic drug for pains and autoimmune diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP1820504A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | IMINE COMPOUND |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T00%3A45%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SEKINE,%20SHINGO&rft.date=2007-08-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1820504A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |